Ionis Pharmaceuticals Inc $ 49.88 -0.16 (-0.32%)
On watch
Volume:
260,871
Avg Vol (1m):
1,033,124
Market Cap $:
6.97 Bil
Enterprise Value $:
5.69 Bil
P/E (TTM):
103.92
P/B:
5.05
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 2.84 | ||
| Equity-to-Asset | 0.45 | ||
| Debt-to-Equity | 0.59 | ||
| Debt-to-EBITDA | 5.28 | ||
| Interest Coverage | 2.37 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 3.75 | ||
| Beneish M-Score | -2.61 | ||
| WACC vs ROIC | |||
Profitability Rank | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 11.93 | ||
| Net Margin % | 7.87 | ||
| ROE % | 5.47 | ||
| ROA % | 2.38 | ||
| ROC (Joel Greenblatt) % | 84.54 | ||
| 3-Year Revenue Growth Rate | 36.6 |
IONS
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 103.92 | ||
| PE Ratio without NRI | 103.92 | ||
| PB Ratio | 5.05 | ||
| PS Ratio | 7.55 | ||
| Price-to-Free-Cash-Flow | 41.89 | ||
| Price-to-Operating-Cash-Flow | 33.28 | ||
| EV-to-EBIT | 41.01 | ||
| EV-to-EBITDA | 36.6 | ||
| EV-to-Revenue | 6.09 | ||
| Current Ratio | 10.37 | ||
| Quick Ratio | 10.28 | ||
| Days Inventory | 803.81 | ||
| Days Payable | 613.13 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 5.15 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 2.11 | ||
| Price-to-Median-PS-Value | 0.6 | ||
| Price-to-Graham-Number | 4.87 | ||
| Earnings Yield (Greenblatt) % | 2.44 |